Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity

被引:104
作者
Wu, Rebecca P. [1 ]
Youngblood, Derek S. [1 ]
Hassinger, Jed N. [1 ]
Lovejoy, Candace E. [1 ]
Nelson, Michelle H. [1 ]
Iversen, Patrick L. [1 ]
Moulton, Hong M. [1 ]
机构
[1] AVI BioPharma Inc, Corvallis, OR 97333 USA
关键词
D O I
10.1093/nar/gkm478
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Arginine-rich cell-penetrating peptides (CPPs) are promising transporters for intracellular delivery of antisense morpholino oligomers (PMO). Here, we determined the effect of L-arginine, D-arginine and non-alpha amino acids on cellular uptake, splice-correction activity, cellular toxicity and serum binding for 24 CPP-PMOs. Insertion of 6-aminohexanoic acid ( X) or beta-alanine ( B) residues into oligoarginine R-8 decreased the cellular uptake but increased the splice-correction activity of the resulting compound, with a greater increase for the sequences containing more X residues. Cellular toxicity was not observed for any of the conjugates up to 10 mu M. Up to 60 mu M, only the conjugates with >= 5 Xs exhibited time- and concentration- dependent toxicity. Substitution of L-arginine with D-arginine did not increase uptake or splice-correction activity. High concentration of serum significantly decreased the uptake and splice-correction activity of oligoarginine conjugates, but had much less effect on the conjugates containing X or B. In summary, incorporation of X/B into oligoarginine enhanced the antisense activity and serum-binding profile of CPP - PMO. Toxicity of X/B-containing conjugates was affected by the number of Xs, treatment time and concentration. More active, stable and less toxic CPPs can be designed by optimizing the position and number of R, D-R, X and B residues.
引用
收藏
页码:5182 / 5191
页数:10
相关论文
共 20 条
[1]   Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents [J].
Abes, Said ;
Moulton, Hong M. ;
Clair, Philippe ;
Prevot, Paul ;
Youngblood, Derek S. ;
Wu, Rebecca P. ;
Iversen, Patrick L. ;
Lebleu, Bernard .
JOURNAL OF CONTROLLED RELEASE, 2006, 116 (03) :304-313
[2]   Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models [J].
Burrer, Renaud ;
Neuman, Benjamin W. ;
Ting, Joey P. C. ;
Stein, David A. ;
Moulton, Hong M. ;
Iversen, Patrick L. ;
Kuhn, Peter ;
Buchmeier, Michael J. .
JOURNAL OF VIROLOGY, 2007, 81 (11) :5637-5648
[3]  
Chan W., 1999, Fmoc solid phase peptide synthesis: a practical approach
[4]   Inhibition of flavivirus infections by antisense oligorners specifically suppressing viral translation and RNA replication [J].
Deas, TS ;
Binduga-Gajewska, I ;
Tilgner, M ;
Ren, P ;
Stein, DA ;
Moulton, HM ;
Iversen, PL ;
Kauffman, EB ;
Kramer, LD ;
Shi, PY .
JOURNAL OF VIROLOGY, 2005, 79 (08) :4599-4609
[5]   In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. [J].
Fischer, D ;
Li, YX ;
Ahlemeyer, B ;
Krieglstein, J ;
Kissel, T .
BIOMATERIALS, 2003, 24 (07) :1121-1131
[6]  
FLETCHER S, 2007, IN PRESS MOL THERAPY
[7]   Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers [J].
Ge, Qing ;
Pastey, Manoj ;
Kobasa, Darwyn ;
Puthavathana, Piliapan ;
Lupfer, Christopher ;
Bestwick, Richard K. ;
Iversen, Patrick L. ;
Chen, Jianzhu ;
Stein, David A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (11) :3724-3733
[8]   Up-regulation of luciferase gene expression with antisense oligonucleotides: Implications and applications in functional assay developments [J].
Kang, SH ;
Cho, MJ ;
Kole, R .
BIOCHEMISTRY, 1998, 37 (18) :6235-6239
[9]   Induced dystrophin exon skipping in human muscle explants [J].
McClorey, G. ;
Fall, A. M. ;
Moulton, H. M. ;
Iversen, P. L. ;
Rasko, J. E. ;
Ryan, M. ;
Fletcher, S. ;
Wilton, S. D. .
NEUROMUSCULAR DISORDERS, 2006, 16 (9-10) :583-590
[10]   Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD [J].
McClorey, G. ;
Moulton, H. M. ;
Iversen, P. L. ;
Fletcher, S. ;
Wilton, S. D. .
GENE THERAPY, 2006, 13 (19) :1373-1381